Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Atovaquone 750mg/5ml oral suspension sugar free |
| BNF code | 0504080A0AAABAB |
| Virtual Therapeutic Moiety | Atovaquone |
| Date identifier became valid | 18 Oct 2018 |
| Previous product identifier | 325007009 |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✓ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 5.000 |
| Unit dose form units | ml |
| Unit dose unit of measure | spoonful |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Atovaquone |
| Basis of pharmaceutical strength | Based on Ingredient Substance |
| Strength value numerator | 150.000 |
| Strength value numerator unit | mg |
| Strength value denominator | 1.000 |
| Strength value denominator unit | ml |
| Ontology Drug Form & Route | |
| Form & Route | suspension.oral |
| Dose Form | |
| Formulation | Oral suspension |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Atovaquone 750mg/5ml oral suspension sugar free (A A H Pharmaceuticals Ltd) | |
| Atovaquone 750mg/5ml oral suspension sugar free (Alliance Healthcare (Distribution) Ltd) | |
| Atovaquone 750mg/5ml oral suspension sugar free (Glenmark Pharmaceuticals Europe Ltd) | |
| Wellvone 750mg/5ml oral suspension (GlaxoSmithKline UK Ltd) | |
| Virtual Medicinal Product Packs | |
| Atovaquone 750mg/5ml oral suspension sugar free 210 ml | |
| Atovaquone 750mg/5ml oral suspension sugar free 226 ml | |
| Atovaquone 750mg/5ml oral suspension sugar free 250 ml | |
dm+d data retrieved from TRUD: release NHSBSA_5.0.0_20240506000001, imported on 6th May 2024 at 05:05:44.